阿尔伯塔省药剂师在执业环境中对处方药滥用和成瘾的做法、观点和信心的评估

IF 1.6 Q3 PHARMACOLOGY & PHARMACY Canadian Pharmacists Journal Pub Date : 2019-08-13 DOI:10.1177/1715163519865914
C. Necyk, Ken Cor, Arianna Mazzuca, L. Meleshko
{"title":"阿尔伯塔省药剂师在执业环境中对处方药滥用和成瘾的做法、观点和信心的评估","authors":"C. Necyk, Ken Cor, Arianna Mazzuca, L. Meleshko","doi":"10.1177/1715163519865914","DOIUrl":null,"url":null,"abstract":"Background: Pharmacists play an important role in managing patients with prescription drug abuse and addiction (PDAA). The objective of this study was to explore Alberta pharmacists’ practices, views and confidence in the management of patients at risk of or living with PDAA in their practice setting. Methods: A 26-question online questionnaire was distributed to 4261 pharmacists across Alberta, of whom 656 (15%) participated. The questionnaire consisted of 17 multiple-choice, 6 multipart and 3 free-response questions. Questionnaire responses were collected and analyzed in Qualtrics. Results: Sixty-six percent (n = 408) of pharmacists indicated that PDAA was prevalent in their practice setting, with 55% (n = 340) of respondents encountering more than 6 patients with suspected or known PDAA a month. Thirty-five percent (n = 198) of pharmacists indicated they were moderately confident at identifying patients with potential PDAA. However, 41% (n = 235) of the pharmacists indicated that they only discuss PDAA with identified patients less than half of the time. Pharmacists lacked confidence in their ability to discuss PDAA treatment options with their patients as well as collaborate with addiction treatment facilities. Lack of training or knowledge in PDAA (48%) and uncertainty of how to initiate discussion or effectively communicate with patients about PDAA (39%) were identified as barriers that significantly or very significantly hindered respondents from managing PDAA in their practice. Conclusions: Although many pharmacists are moderately confident in identifying patients with potential PDAA, several barriers hinder intervention. Providing pharmacists with additional training and resources may better equip them to manage PDAA within their practice settings. Can Pharm J (Ott) 2019;152:xx-xx.","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"376 - 387"},"PeriodicalIF":1.6000,"publicationDate":"2019-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519865914","citationCount":"4","resultStr":"{\"title\":\"An evaluation of Alberta pharmacists’ practices, views and confidence regarding prescription drug abuse and addiction within their practice setting\",\"authors\":\"C. Necyk, Ken Cor, Arianna Mazzuca, L. Meleshko\",\"doi\":\"10.1177/1715163519865914\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Pharmacists play an important role in managing patients with prescription drug abuse and addiction (PDAA). The objective of this study was to explore Alberta pharmacists’ practices, views and confidence in the management of patients at risk of or living with PDAA in their practice setting. Methods: A 26-question online questionnaire was distributed to 4261 pharmacists across Alberta, of whom 656 (15%) participated. The questionnaire consisted of 17 multiple-choice, 6 multipart and 3 free-response questions. Questionnaire responses were collected and analyzed in Qualtrics. Results: Sixty-six percent (n = 408) of pharmacists indicated that PDAA was prevalent in their practice setting, with 55% (n = 340) of respondents encountering more than 6 patients with suspected or known PDAA a month. Thirty-five percent (n = 198) of pharmacists indicated they were moderately confident at identifying patients with potential PDAA. However, 41% (n = 235) of the pharmacists indicated that they only discuss PDAA with identified patients less than half of the time. Pharmacists lacked confidence in their ability to discuss PDAA treatment options with their patients as well as collaborate with addiction treatment facilities. Lack of training or knowledge in PDAA (48%) and uncertainty of how to initiate discussion or effectively communicate with patients about PDAA (39%) were identified as barriers that significantly or very significantly hindered respondents from managing PDAA in their practice. Conclusions: Although many pharmacists are moderately confident in identifying patients with potential PDAA, several barriers hinder intervention. Providing pharmacists with additional training and resources may better equip them to manage PDAA within their practice settings. Can Pharm J (Ott) 2019;152:xx-xx.\",\"PeriodicalId\":46612,\"journal\":{\"name\":\"Canadian Pharmacists Journal\",\"volume\":\"152 1\",\"pages\":\"376 - 387\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2019-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/1715163519865914\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Pharmacists Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1715163519865914\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Pharmacists Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1715163519865914","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 4

摘要

背景:药剂师在管理处方药滥用和成瘾(PDAA)患者方面发挥着重要作用。本研究的目的是探讨阿尔伯塔省药剂师在其执业环境中对有PDAA风险或患有PDAA的患者进行管理的做法、观点和信心。方法:向阿尔伯塔省4261名药剂师分发了一份26个问题的在线问卷,其中656人(15%)参加了问卷调查。问卷由17个多项选择题、6个多部分问题和3个自由回答问题组成。在Qualtrics中收集并分析问卷回复。结果:66%(n=408)的药剂师表示,PDAA在他们的执业环境中很普遍,55%(n=340)的受访者每月遇到6名以上疑似或已知PDAA患者。35%(n=198)的药剂师表示,他们对识别潜在PDAA患者有一定的信心。然而,41%(n=235)的药剂师表示,他们只在不到一半的时间内与已确定的患者讨论PDAA。药剂师对他们与患者讨论PDAA治疗方案以及与成瘾治疗机构合作的能力缺乏信心。缺乏PDAA方面的培训或知识(48%)以及如何与患者就PDAA展开讨论或有效沟通的不确定性(39%)被认为是严重或非常严重阻碍受访者在实践中管理PDAA的障碍。结论:尽管许多药剂师对识别潜在PDAA患者有一定的信心,但有几个障碍阻碍了干预。为药剂师提供额外的培训和资源可以更好地让他们在执业环境中管理PDAA。Can Pharm J(Ott)2019;152:xx-xx。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
An evaluation of Alberta pharmacists’ practices, views and confidence regarding prescription drug abuse and addiction within their practice setting
Background: Pharmacists play an important role in managing patients with prescription drug abuse and addiction (PDAA). The objective of this study was to explore Alberta pharmacists’ practices, views and confidence in the management of patients at risk of or living with PDAA in their practice setting. Methods: A 26-question online questionnaire was distributed to 4261 pharmacists across Alberta, of whom 656 (15%) participated. The questionnaire consisted of 17 multiple-choice, 6 multipart and 3 free-response questions. Questionnaire responses were collected and analyzed in Qualtrics. Results: Sixty-six percent (n = 408) of pharmacists indicated that PDAA was prevalent in their practice setting, with 55% (n = 340) of respondents encountering more than 6 patients with suspected or known PDAA a month. Thirty-five percent (n = 198) of pharmacists indicated they were moderately confident at identifying patients with potential PDAA. However, 41% (n = 235) of the pharmacists indicated that they only discuss PDAA with identified patients less than half of the time. Pharmacists lacked confidence in their ability to discuss PDAA treatment options with their patients as well as collaborate with addiction treatment facilities. Lack of training or knowledge in PDAA (48%) and uncertainty of how to initiate discussion or effectively communicate with patients about PDAA (39%) were identified as barriers that significantly or very significantly hindered respondents from managing PDAA in their practice. Conclusions: Although many pharmacists are moderately confident in identifying patients with potential PDAA, several barriers hinder intervention. Providing pharmacists with additional training and resources may better equip them to manage PDAA within their practice settings. Can Pharm J (Ott) 2019;152:xx-xx.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Canadian Pharmacists Journal
Canadian Pharmacists Journal PHARMACOLOGY & PHARMACY-
CiteScore
2.50
自引率
26.70%
发文量
43
期刊介绍: Established in 1868, the Canadian Pharmacists Journal is the oldest continuously published periodical in Canada. Our mission is to enhance patient care through advancement of pharmacy practice, with continuing professional development, peer-reviewed research, and advocacy. Our vision is to become the foremost journal for pharmacy practice and research.
期刊最新文献
The role of Alberta pharmacists working in opioid use disorder and their potential to prescribe buprenorphine-naloxone: A qualitative study. Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists' perspectives. Lyme disease chemoprophylaxis prescribing before and after pharmacist prescriptive authority in Nova Scotia. Enabling pharmacist prescribing: Lessons learned in Nova Scotia using behaviour change theory. British Columbia community pharmacy during COVID-19: Describing the patient experience via Google reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1